TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Afya ( (AFYA) ) has shared an update.
On November 12, 2025, Afya Limited announced its financial results for the third quarter and the first nine months of 2025, ending September 30. The company reported a 10.4% year-over-year increase in third-quarter revenue to R$928.5 million, with adjusted EBITDA rising 14.6% to R$398.9 million, reflecting a margin expansion to 43.0%. Net income for the quarter increased by 28.4% to R$159.4 million. For the nine-month period, revenue grew by 13.4% to R$2,784.3 million, and adjusted EBITDA increased by 18.5% to R$1,291.7 million. Afya also highlighted its strategic initiatives, including AI-enabled enhancements and the launch of Instituto Afya, aimed at long-term value creation. In October, the company issued R$1.5 billion in commercial notes to strengthen its capital structure, repurchasing shares and repaying debt, which underscores its disciplined capital management approach.
The most recent analyst rating on (AFYA) stock is a Buy with a $25.50 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust revenue growth, efficient cost management, and strategic initiatives like the share repurchase program highlight its potential for future growth. Technical analysis and valuation are supportive but less impactful, with the stock showing neutral momentum and reasonable valuation metrics.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya Limited is a leading medical education group and provider of medical practice solutions in Brazil. The company focuses on integrating education and medical practice solutions throughout the medical journey, offering undergraduate and continuing education programs as well as clinical management solutions.
Average Trading Volume: 102,448
Technical Sentiment Signal: Sell
Current Market Cap: $1.29B
See more insights into AFYA stock on TipRanks’ Stock Analysis page.